In 2020 Paul Heppenstall and EMBLEM co-founded Borea Therapeutics to develop a platform of next-generation viral vectors for targeted gene therapy. [...] Borea's research activities are performed in collaboration with the Scuola Internazionale Superiore di Studi Avanzati (SISSA).
Media source
Main topic
(ex) SISSA person
Is it triggered by our press release/brief?
No
Copy and paste of our text?
No
Interview organised by us (with/without press release or note, comment, event, etc…)
No
Copy and paste of an agency news (wherever it comes from)?
No
d7_username
Federica Gerini (fgerini)
d7_useremail
fgerini@sissa.it